Position in GSK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$8,364,554
-$522,746 QoQ
Shares Held
159,568
-0.9% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#120
of 1,034 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HANTZ FINANCIAL SERVICES, INC. holds $94,295,990 across 14 Drug Manufacturers - General names. GSK ranks #6 (8.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
84,317 | $21,413,988 | |
| 2 | LLY |
ELI LILLY & Co
|
10,017 | $12,014,691 | |
| 3 | ABBV |
AbbVie Inc.
|
45,381 | $11,419,674 | |
| 4 | NVS |
Novartis AG
|
68,779 | $10,779,044 | |
| 5 | MRK |
Merck & Co., Inc.
|
66,636 | $8,562,726 | |
| 6 | GSK |
GSK plc
This page
|
159,568 | $8,364,554 | |
| 7 | NVO |
Novo Nordisk A S
|
117,306 | $5,623,649 | |
| 8 | AZN |
Astrazeneca PLC
|
23,610 | $4,476,928 |
All Filings in GSK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,364,554 | 159,568 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $8,887,300 | 161,031 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $7,402,980 | 150,958 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $5,699,450 | 132,054 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $4,210,982 | 109,661 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $3,957,136 | 102,146 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $2,956,409 | 87,416 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $3,252,331 | 79,558 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,031,682 | 78,745 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $3,493,519 | 81,491 | Shares | Sole | 2024-08-06 | |
| 2023-12-31 | $3,002,897 | 81,028 | Shares | Sole | 2024-08-06 | |
| 2023-09-30 | $2,970,868 | 81,955 | Shares | Sole | 2024-08-06 | |
| 2023-06-30 | $2,741,927 | 76,934 | Shares | Sole | 2024-08-06 | |
| 2023-03-31 | $2,653,769 | 74,586 | Shares | Sole | 2024-08-06 | |
| 2022-12-31 | $2,503,584 | 71,246 | Shares | Sole | 2024-08-06 | |
| 2022-09-30 | $1,953,475 | 66,377 | Shares | Sole | 2024-08-06 | |
| 2022-06-30 | $3,466,173 | 81,186 | Shares | Sole | 2024-08-06 | |
| 2022-03-31 | $3,318,516 | 77,674 | Shares | Sole | 2024-08-06 | |
| 2021-12-31 | $2,962,503 | 68,492 | Shares | Sole | 2024-08-06 | |
| 2021-09-30 | $2,279,462 | 60,824 | Shares | Sole | 2024-08-06 | |
| 2021-06-30 | $1,924,691 | 49,281 | Shares | Sole | 2024-08-06 | |
| 2021-03-31 | $1,196,672 | 34,186 | Shares | Sole | 2024-08-06 | |
| 2020-12-31 | $945,828 | 26,205 | Shares | Sole | 2024-08-06 | |
| 2020-09-30 | $1,221,593 | 33,090 | Shares | Sole | 2024-08-06 | |
| 2020-06-30 | $1,383,956 | 34,593 | Shares | Sole | 2024-08-06 | |
| 2020-03-31 | $1,320,867 | 35,543 | Shares | Sole | 2024-08-06 | |
| No filing history on record for this holder in this stock. | ||||||